Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
REVENUES
Product sales - net	$ 18	$ 1,271
Service and repair fees - net	2,284	2,491
Service and repair fees - related parties - net	28	28
Patient fee revenue, net of contractual allowances and discounts	8,114	6,787
Provision for bad debts for patient fee	(3,507)	(3,146)
Management and other fees - net	8,829	8,738
Management and other fees - related medical practices - net	1,845	1,816
Total Revenues - Net	17,611	17,985
COSTS AND EXPENSES
Costs related to product sales	112	1,085
Costs related to service and repair fees	543	507
Costs related to service and repair fees - related parties	7	6
Costs related to patient fee revenue	2,228	1,899
Costs related to management and other fees	5,419	5,590
Costs related to management and other fees - related medical practices	1,058	979
Research and development	436	397
Selling, general and administrative	3,775	3,578
Provision for bad debts	418	506
Total Costs and Expenses	13,996	14,547
INCOME
Income From Operations	3,615	3,438
Interest Expense	(150)	(204)
Investment Income	50	62
Income Before Provision for Income Taxes and Noncontrolling Interests	3,515	3,296
Provision for Income Taxes	50	40
Net Income	3,465	3,256
Net Income - Noncontrolling Interests	(603)	(721)
Net Income - Controlling Interests	$ 2,862	$ 2,535
Basic Net Income Per Common Share	$ 0.47	$ 0.42
Weighted Average Basic Shares Outstanding	6,050,000	6,050,000
Common Stock
INCOME
Net Income - Controlling Interests	$ 2,676	$ 2,370
Basic Net Income Per Common Share	$ 0.44	$ 0.39
Diluted Net Income Per Common Share	$ 0.43	$ 0.38
Weighted Average Basic Shares Outstanding	6,050,000	6,050,000
Weighted Average Diluted Shares Outstanding	6,178,000	6,178,000
Preferred Stock Class A
INCOME
Net Income - Controlling Interests	$ 139	$ 123
Class C Common Stock
INCOME
Net Income - Controlling Interests	$ 47	$ 42
Basic Net Income Per Common Share	$ 0.12	$ 0.11
Diluted Net Income Per Common Share	$ 0.12	$ 0.11
Weighted Average Basic Shares Outstanding	383,000	383,000
Weighted Average Diluted Shares Outstanding	383,000	383,000